Omega Healthcare Investors (OHI) Cash & Equivalents (2016 - 2026)
Omega Healthcare Investors' Cash & Equivalents history spans 18 years, with the latest figure at $26.1 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 92.89% to $26.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $26.1 million, a 92.89% decrease, with the full-year FY2025 number at $27.0 million, down 94.79% from a year prior.
- Cash & Equivalents hit $26.1 million in Q1 2026 for Omega Healthcare Investors, down from $27.0 million in the prior quarter.
- Over the last five years, Cash & Equivalents for OHI hit a ceiling of $737.2 million in Q3 2025 and a floor of $6.9 million in Q3 2024.
- Historically, Cash & Equivalents has averaged $323.3 million across 5 years, with a median of $350.7 million in 2023.
- Biggest five-year swings in Cash & Equivalents: plummeted 98.76% in 2024 and later soared 10636.76% in 2025.
- Tracing OHI's Cash & Equivalents over 5 years: stood at $297.1 million in 2022, then skyrocketed by 49.04% to $442.8 million in 2023, then rose by 17.06% to $518.3 million in 2024, then tumbled by 94.79% to $27.0 million in 2025, then dropped by 3.24% to $26.1 million in 2026.
- Business Quant data shows Cash & Equivalents for OHI at $26.1 million in Q1 2026, $27.0 million in Q4 2025, and $737.2 million in Q3 2025.